Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients

被引:0
|
作者
Ghavamzadeh, A. [1 ]
Alimogaddam, K. [1 ]
Khatami, F. [1 ]
Gaffari, F. [1 ]
Ashuri, A. [1 ]
Mousavi, A. [1 ]
Iravani, M. [1 ]
Bahar, B. [1 ]
Jahani, M. [1 ]
Khodabande, A. [1 ]
机构
[1] Hematol Oncol & Bone Marrow Transplantat Res Ctr, Tehran, Iran
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S133 / S134
页数:2
相关论文
共 50 条
  • [31] Busilvex in combination with etoposide and melphalan as conditioning regimen in autologous haematopoietic cell transplantation for lymphomas: efficacy and safety
    Sakellari, I.
    Mallouri, D.
    Constantinou, V.
    Baliakas, P.
    Iskas, M.
    Karypidis, K.
    Apostolou, C.
    Kaloyannidis, P.
    Batsis, I.
    Vadikoliou, C.
    Papaemmanouil, S.
    Palladas, P.
    Smias, C.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S450 - S450
  • [32] Mitoxantrone and melphalan as a conditioning regimen for autologous peripheral blood stem cell transplantation in adults with acute myelogenous leukemia
    Sprague, KA
    Padgaonkar, VA
    Klein, AK
    Chan, GW
    Miller, KB
    Klingemann, H
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 93 - 94
  • [33] APPLICATION OF CONDITIONING REGIMEN WITH BUSULFAN AND CYCLOPHOSPHAMIDE IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Xu, Y.
    Fu, C.
    Yao, Y.
    Yao, W.
    Jin, S.
    Yan, L.
    Shang, J.
    Zhu, X.
    Sun, A.
    Wu, D.
    HAEMATOLOGICA, 2017, 102 : 787 - 787
  • [34] High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in acute myeloid leukaemia
    Ferrara, F
    Palmieri, S
    De Simone, M
    D'Amico, MR
    Fasanaro, A
    Viola, A
    Annunziata, M
    Mele, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S233 - S233
  • [35] INTRAVENOUS BUSULFAN IN AUTOLOGOUS STEM CELL TRANSPLANTATION CONDITIONING REGIMEN FOR ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA. MULTICENTRE RETROSPECTIVE ANALYSIS
    Grande, C.
    Garcia Sanchez, P. J.
    de la Rubia, J.
    Serrano, D.
    Lopez Duarte, M.
    Garcia Boyero, R.
    Rosique, P.
    Heras, I.
    Martinez, R.
    Lahuerta, J. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 292 - 293
  • [36] Application of the Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Xu, Yun
    Yao, Ying
    Yao, Weiqin
    Jin, Song
    Yan, Lingzhi
    Shang, Jingjing
    Fu, Chengcheng
    Wu, Depei
    BLOOD, 2017, 130
  • [37] Cytoreduction and stem cell mobilization with a regimen of paclitaxel, etoposide and cyclophosphamide followed by autologous transplantation using a preparative regimen of busulfan, etoposide and cyclophosphamide for patients with advanced lymphoma
    Tutschka, PJ
    Bilgrami, SA
    Feingold, JM
    Edwards, RL
    Bona, RD
    Naqvi, B
    Clive, J
    ACTA HAEMATOLOGICA, 2001, 105 (04) : 222 - 232
  • [38] Outcome of autologous haematopoietic stem cell transplantation in adults with acute myeloid leukaemia using three different conditioning regimens
    Rasheed, W.
    Al Mohareb, F.
    Bakr, M.
    Chaudhri, N.
    Alsharif, F.
    Mohamed, S. Y.
    Saleh, A. J. M.
    Ibrahim, K.
    Ahmed, S.
    Chebbo, W.
    El Gohary, G.
    Bashir, M.
    Elghazaly, A.
    Nurgat, Z.
    Hussain, F.
    ElHassan, T.
    Aljurf, M.
    Al Zahrani, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S276 - S276
  • [39] Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
    Lin, Meng
    Wu, Xiaolong
    Zhang, Lei
    Li, Ling
    Wang, Xinhua
    Fu, Xiaorui
    Sun, Zhenchang
    Zhang, Xudong
    Zhu, Linan
    Yu, Hui
    Chang, Yu
    Nan, Feifei
    Yan, Jiaqin
    Zhou, Zhiyuan
    Shi, Cunzhen
    Zhang, Mingzhi
    Li, Xin
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 605 - 612
  • [40] Mitoxantrone and melphalan conditioning regimen for autologous peripheral blood stem cell transplantation in adults with acute myelogenous leukemia.
    Sprague, K
    Padgaonkar, V
    Klein, AK
    Chan, GW
    Miller, KB
    Klingemann, H
    BLOOD, 2005, 106 (11) : 466B - 466B